NCT03663855View on ClinicalTrials.gov

Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

September 10, 2019

Study Completion Date

September 10, 2019

Conditions
Cystinuria
Interventions
DRUG

Tiopronin

Phase 1: No medication, Phase 2: 500mg PO daily x 7 days (total 500mg), Phase 3: 500mg PO BID x 7 days (total 1g), Phase 4: 1g PO BID x 7 days (total 2g)

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03663855 - Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria | Biotech Hunter | Biotech Hunter